Aptiv is trading at $49.12, up 6.09%, rebounding after its sharp August 4 earnings selloff.

  • Investors focused on reduced full-year guidance after earnings.
  • Management cut 2026 revenue guidance to $12.6–$12.8 billion, citing China weakness and delayed program launches.
  • No reliable, company-specific announcement or analyst action dated August 7, 2026 was found to directly explain the intraday rebound; the move may reflect trading recovery after the earlier decline.